Applied Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)

Applied Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)

Applied Therapeutics, Inc. reported Diluted Shares Outstanding (Weighted Average) of 145.56 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-11-13

• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 145.56M shares, a 0.84% increase year-over-year.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 145.09M shares, a 4.79% decline year-over-year.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 144.79M shares, a 15.54% increase year-over-year.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 144.46M shares, a 30.70% increase year-over-year.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 139.53M shares, a 65.63% increase from fiscal 2023.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 84.24M shares, a 122.72% increase from fiscal 2022.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 37.83M shares, a 47.77% increase from fiscal 2021.
• Applied Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 25.60M shares, a 16.53% increase from fiscal 2020.